Myocardial Infarction Articles

Articles
Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta-Analysis of Randomized Trials and Systematic Review
Rahman H, Khan SU, Lone AN, et al.
Journal:
J Am Heart Assoc

First published: August 10, 2023 DOI: 10.1161/JAHA.123.030578
View
- Share
Articles
Low-density lipoprotein cholesterol cannot be too low after a myocardial infarction
Wulff AB, Mortensen MB, Nordestgaard BG
Journal:
J Intern Med

First published: July 16, 2023 DOI: 10.1111/joim.13694
View
- Share
Articles
Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort: A Prospective Observational Cohort Study
Fuchs A, Kühl JT, Sigvardsen PE, et al.
Journal:
Ann Intern Med

First published: March 23, 2023 DOI: 10.7326/M22-3027
View
- Share
Articles
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial
Mehta SR, Pare G, Lonn EM, et al.
Journal:
EuroIntervention

First published: December 2, 2022 DOI: 10.4244/EIJ-D-22-00735
View
- Share
Articles
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials
Ray KK, Raal FJ, Kallend DG, et al.
Journal:
Eur Heart J

First published: November 4, 2022 DOI: 10.1093/eurheartj/ehac594
View
- Share
Articles
Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease
Nissen SE, Wolski K, Cho L, et al.
Journal:
Open Heart

First published: October 17, 2022 DOI: 10.1136/openhrt-2022-002060
View
- Share
Articles
Projected Impact of Treatment Intensification with Satin, Ezetimibe, and Statin plus Ezetimibe Fixed-Dose Combination on MACE Across Six Countries
Farnier M, Santos RD, Cosin-Sales J, et al.
Journal:
Eur J Prev Cardiol

First published: September 22, 2022 DOI: 10.1093/eurjpc/zwac214
View
- Share
Articles
Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B
Bonaca MP, Morrow DA, Bergmark BA, et al.
Journal:
Circulation

First published: August 30, 2022 DOI: 10.1161/CIRCULATIONAHA.122.059325
View
- Share
Articles
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
Wilson DP, Jacobson TA, Jones PH, et al.
Journal:
Journal of Clinical Lipidology

First published: August 28, 2022 DOI: 10.1016/j.jacl.2022.08.007
View
- Share
Articles
High lipoprotein(a) levels predict severity of coronary artery disease in patients hospitalized for acute myocardial infarction. Data from the French RICO survey
Farnier M, Chagué F, Maza M, et al.
Journal:
J Clin Lipidol

First published: July 17, 2022 DOI: 10.1016/j.jacl.2022.07.006
View
- Share
Articles
Causes, Angiographic Characteristics, and Management of Premature Myocardial Infarction: JACC State-of-the-Art Review
Rallidis LS, Xenogiannis I, Brilakis ES, et al.
Journal:
J Am Coll Cardiol

First published: June 21, 2022 DOI: 10.1016/j.jacc.2022.04.015
View
- Share
Articles
Shining a Light on Plaque Vulnerability and Treatment
Stone GW, Narula J
Journal:
JACC Cardiovasc Imaging

First published: June 15, 2022 DOI: 10.1016/j.jcmg.2022.04.019
View
- Share

1 2

Myocardial Infarction Articles

Articles

Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta-Analysis of Randomized Trials and Systematic Review

Rahman H, Khan SU, Lone AN, et al.

Articles

Low-density lipoprotein cholesterol cannot be too low after a myocardial infarction

Wulff AB, Mortensen MB, Nordestgaard BG

Articles

Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort: A Prospective Observational Cohort Study

Fuchs A, Kühl JT, Sigvardsen PE, et al.

Articles

Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial

Mehta SR, Pare G, Lonn EM, et al.

Articles

Inclisiran and cardiovascular events: a patient-level analysis of phase III trials

Ray KK, Raal FJ, Kallend DG, et al.

Articles

Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease

Nissen SE, Wolski K, Cho L, et al.

Articles

Projected Impact of Treatment Intensification with Satin, Ezetimibe, and Statin plus Ezetimibe Fixed-Dose Combination on MACE Across Six Countries

Farnier M, Santos RD, Cosin-Sales J, et al.

Articles

Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B

Bonaca MP, Morrow DA, Bergmark BA, et al.

Articles

Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association

Wilson DP, Jacobson TA, Jones PH, et al.

Articles

High lipoprotein(a) levels predict severity of coronary artery disease in patients hospitalized for acute myocardial infarction. Data from the French RICO survey

Farnier M, Chagué F, Maza M, et al.

Articles

Causes, Angiographic Characteristics, and Management of Premature Myocardial Infarction: JACC State-of-the-Art Review

Rallidis LS, Xenogiannis I, Brilakis ES, et al.

Articles

Shining a Light on Plaque Vulnerability and Treatment

Stone GW, Narula J

Articles

Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta-Analysis of Randomized Trials and Systematic Review

Rahman H, Khan SU, Lone AN, et al.

Share

Articles

Low-density lipoprotein cholesterol cannot be too low after a myocardial infarction

Wulff AB, Mortensen MB, Nordestgaard BG

Share

Articles

Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort: A Prospective Observational Cohort Study

Fuchs A, Kühl JT, Sigvardsen PE, et al.

Share

Articles

Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial

Mehta SR, Pare G, Lonn EM, et al.

Share

Articles

Inclisiran and cardiovascular events: a patient-level analysis of phase III trials

Ray KK, Raal FJ, Kallend DG, et al.

Share

Articles

Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease

Nissen SE, Wolski K, Cho L, et al.

Share

Articles

Projected Impact of Treatment Intensification with Satin, Ezetimibe, and Statin plus Ezetimibe Fixed-Dose Combination on MACE Across Six Countries

Farnier M, Santos RD, Cosin-Sales J, et al.

Share

Articles

Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B

Bonaca MP, Morrow DA, Bergmark BA, et al.

Share

Articles

Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association

Wilson DP, Jacobson TA, Jones PH, et al.

Share

Articles

High lipoprotein(a) levels predict severity of coronary artery disease in patients hospitalized for acute myocardial infarction. Data from the French RICO survey

Farnier M, Chagué F, Maza M, et al.

Share

Articles

Causes, Angiographic Characteristics, and Management of Premature Myocardial Infarction: JACC State-of-the-Art Review

Rallidis LS, Xenogiannis I, Brilakis ES, et al.

Share

Articles

Shining a Light on Plaque Vulnerability and Treatment

Stone GW, Narula J

Share